Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 2
2000 1
2002 2
2003 3
2004 1
2010 1
2011 1
2014 1
2017 2
2018 2
2019 2
2020 2
2021 4
2022 5
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for france buelow
Your search for Franca Buelow retrieved no results
TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity.
Ugamraj HS, Dang K, Ouisse LH, Buelow B, Chini EN, Castello G, Allison J, Clarke SC, Davison LM, Buelow R, Deng R, Iyer S, Schellenberger U, Manika SN, Bijpuria S, Musnier A, Poupon A, Cuturi MC, van Schooten W, Dalvi P. Ugamraj HS, et al. MAbs. 2022 Jan-Dec;14(1):2095949. doi: 10.1080/19420862.2022.2095949. MAbs. 2022. PMID: 35867844 Free PMC article.
Overall, TNB-738 represents a novel treatment with broad therapeutic potential for metabolic and inflammatory diseases associated with NAD+ deficiencies.Abbreviations: 7-AAD: 7-aminoactinomycin D; ADCC: antibody dependent cell-mediated cytotoxicity; ADCP: antibody dependent cell- …
Overall, TNB-738 represents a novel treatment with broad therapeutic potential for metabolic and inflammatory diseases associated with NAD+ …
Benchmarking weakly-supervised deep learning pipelines for whole slide classification in computational pathology.
Ghaffari Laleh N, Muti HS, Loeffler CML, Echle A, Saldanha OL, Mahmood F, Lu MY, Trautwein C, Langer R, Dislich B, Buelow RD, Grabsch HI, Brenner H, Chang-Claude J, Alwers E, Brinker TJ, Khader F, Truhn D, Gaisa NT, Boor P, Hoffmeister M, Schulz V, Kather JN. Ghaffari Laleh N, et al. Med Image Anal. 2022 Jul;79:102474. doi: 10.1016/j.media.2022.102474. Epub 2022 May 4. Med Image Anal. 2022. PMID: 35588568 Free article.
Adversarial attacks and adversarial robustness in computational pathology.
Ghaffari Laleh N, Truhn D, Veldhuizen GP, Han T, van Treeck M, Buelow RD, Langer R, Dislich B, Boor P, Schulz V, Kather JN. Ghaffari Laleh N, et al. Nat Commun. 2022 Sep 29;13(1):5711. doi: 10.1038/s41467-022-33266-0. Nat Commun. 2022. PMID: 36175413 Free PMC article.
Future carbon emissions from global mangrove forest loss.
Adame MF, Connolly RM, Turschwell MP, Lovelock CE, Fatoyinbo T, Lagomasino D, Goldberg LA, Holdorf J, Friess DA, Sasmito SD, Sanderman J, Sievers M, Buelow C, Kauffman JB, Bryan-Brown D, Brown CJ. Adame MF, et al. Glob Chang Biol. 2021 Jun;27(12):2856-2866. doi: 10.1111/gcb.15571. Epub 2021 Mar 17. Glob Chang Biol. 2021. PMID: 33644947 Free PMC article.
Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies.
Clarke SC, Ma B, Trinklein ND, Schellenberger U, Osborn MJ, Ouisse LH, Boudreau A, Davison LM, Harris KE, Ugamraj HS, Balasubramani A, Dang KH, Jorgensen B, Ogana HAN, Pham DT, Pratap PP, Sankaran P, Anegon I, van Schooten WC, Brüggemann M, Buelow R, Force Aldred S. Clarke SC, et al. Front Immunol. 2019 Jan 7;9:3037. doi: 10.3389/fimmu.2018.03037. eCollection 2018. Front Immunol. 2019. PMID: 30666250 Free PMC article.
Characterization of immunoglobulin heavy chain knockout rats.
Ménoret S, Iscache AL, Tesson L, Rémy S, Usal C, Osborn MJ, Cost GJ, Brüggemann M, Buelow R, Anegon I. Ménoret S, et al. Eur J Immunol. 2010 Oct;40(10):2932-41. doi: 10.1002/eji.201040939. Eur J Immunol. 2010. PMID: 21038471 Free article.
28 results